Smart Arginine-Equipped Polycationic Nanoparticles for P/Crispr Delivery Into Cells Publisher Pubmed



Moradi P^{1, 2, 3} ; Hasanzadeh A² ; Radmanesh F^{4, 5} ; Rajai Daryasarei S² ; Hosseini ES² ; Kiani J^{6, 7} ; Shahbazi A⁸ ; Nourizadeh H² ; Eslami M^{3, 9} ; Dorgalaleh A¹⁰ ; Sahlolbei M⁷ ; Hamblin MR¹¹ ; Karimi M^{1, 2, 6, 12, 13, 14} Show Affiliations
Source: Nanotechnology Published:2022

Abstract

An efficient and safe delivery system for the transfection of CRISPR plasmid (p/CRISPR) into target cells can open new avenues for the treatment of various diseases. Herein, we design a novel nonvehicle by integrating an arginine-disulfide linker with low-molecular-weight PEI (PEI1.8k) for the delivery of p/CRISPR. These PEI1.8k-Arg nanoparticles facilitate the plasmid release and improve both membrane permeability and nuclear localization, thereby exhibiting higher transfection efficiency compared to native PEI1.8k in the delivery of nanocomplexes composed of PEI1.8k-Arg and p/CRISPR into conventional cells (HEK 293T). This nanovehicle is also able to transfect p/CRISPR in a wide variety of cells, including hard-to-transfect primary cells (HUVECs), cancer cells (HeLa), and neuronal cells (PC-12) with nearly 5-10 times higher efficiency compared to the polymeric gold standard transfection agent. Furthermore, the PEI1.8k-Arg nanoparticles can edit the GFP gene in the HEK 293T-GFP reporter cell line by delivering all possible forms of CRISPR/Cas9 system (e.g. plasmid encoding Cas9 and sgRNA targeting GFP, and Cas9/sgRNA ribonucleoproteins (RNPs) as well as Cas9 expression plasmid and in vitro-prepared sgRNA) into HEK 293T-GFP cells. The successful delivery of p/CRISPR into local brain tissue is also another remarkable capability of these nanoparticles. In view of all the exceptional benefits of this safe nanocarrier, it is expected to break new ground in the field of gene editing, particularly for therapeutic purposes. © 2021 IOP Publishing Ltd.